315 related articles for article (PubMed ID: 32129902)
1. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.
Florio AA; Ferlay J; Znaor A; Ruggieri D; Alvarez CS; Laversanne M; Bray F; McGlynn KA; Petrick JL
Cancer; 2020 Jun; 126(11):2666-2678. PubMed ID: 32129902
[TBL] [Abstract][Full Text] [Related]
2. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
[TBL] [Abstract][Full Text] [Related]
4. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
Bertuccio P; Malvezzi M; Carioli G; Hashim D; Boffetta P; El-Serag HB; La Vecchia C; Negri E
J Hepatol; 2019 Jul; 71(1):104-114. PubMed ID: 30910538
[TBL] [Abstract][Full Text] [Related]
5. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
Saha SK; Zhu AX; Fuchs CS; Brooks GA
Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
[TBL] [Abstract][Full Text] [Related]
6. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification.
Tyson GL; Ilyas JA; Duan Z; Green LK; Younes M; El-Serag HB; Davila JA
Dig Dis Sci; 2014 Dec; 59(12):3103-10. PubMed ID: 25204668
[TBL] [Abstract][Full Text] [Related]
7. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang Y; Wiangnon S; Sripa B; Hong ST
Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
[TBL] [Abstract][Full Text] [Related]
8. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.
Petrick JL; Yang B; Altekruse SF; Van Dyke AL; Koshiol J; Graubard BI; McGlynn KA
PLoS One; 2017; 12(10):e0186643. PubMed ID: 29049401
[TBL] [Abstract][Full Text] [Related]
10. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
[No Abstract] [Full Text] [Related]
11. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study.
Erichsen R; Olén O; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):886-894. PubMed ID: 33627380
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of cholangiocarcinoma.
Shaib Y; El-Serag HB
Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
[TBL] [Abstract][Full Text] [Related]
15. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
Welzel TM; McGlynn KA; Hsing AW; O'Brien TR; Pfeiffer RM
J Natl Cancer Inst; 2006 Jun; 98(12):873-5. PubMed ID: 16788161
[TBL] [Abstract][Full Text] [Related]
16. Secular trends of intrahepatic cholangiocarcinoma in a high endemic area: A population-based study.
Lin CR; Lee YK; Chiang CJ; Yang YW; Chang HC; You SL
World J Gastroenterol; 2022 Jul; 28(28):3695-3705. PubMed ID: 36161044
[TBL] [Abstract][Full Text] [Related]
17. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB
J Hepatol; 2012 Apr; 56(4):848-54. PubMed ID: 22173164
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
Qu Z; Cui N; Qin M; Wu X
Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
[TBL] [Abstract][Full Text] [Related]
19. The epidemiological trends of biliary tract cancers in the United States of America.
Jiang Y; Jiang L; Li F; Li Q; Yuan S; Huang S; Fu Y; Yan X; Chen J; Li H; Li S; Liu J
BMC Gastroenterol; 2022 Dec; 22(1):546. PubMed ID: 36581813
[TBL] [Abstract][Full Text] [Related]
20. Patterns and Trends of Liver Cancer Incidence Rates in Eastern and Southeastern Asian Countries (1983-2007) and Predictions to 2030.
Wu J; Yang S; Xu K; Ding C; Zhou Y; Fu X; Li Y; Deng M; Wang C; Liu X; Li L
Gastroenterology; 2018 May; 154(6):1719-1728.e5. PubMed ID: 29549041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
